Invega Sustenna and Invega Trinza Prior Authorization
Customize your policy alerts
Sign up for all venturacountyhealthcareplan policy alerts
Know when venturacountyhealthcareplan releases new policies or updates existing guidance.
Monitor payer policy activity
Prior authorization coverage for the long-acting injectable paliperidone formulations Invega Sustenna and Invega Trinza in adults with schizophrenia or schizoaffective disorder.
The policy updated its preauthorization criteria on February 18, 2025.
The policy added a Beers Criteria note addressing antipsychotic risks in older adults and patients with dementia or delirium.
The policy added an adverse-reactions section listing central nervous system depression, tachycardia, dystonias, and Parkinsonism.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.